1. Home
  2. ADVM vs NHTC Comparison

ADVM vs NHTC Comparison

Compare ADVM & NHTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • NHTC
  • Stock Information
  • Founded
  • ADVM 2006
  • NHTC 1988
  • Country
  • ADVM United States
  • NHTC United States
  • Employees
  • ADVM N/A
  • NHTC N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • NHTC Diversified Commercial Services
  • Sector
  • ADVM Health Care
  • NHTC Miscellaneous
  • Exchange
  • ADVM Nasdaq
  • NHTC Nasdaq
  • Market Cap
  • ADVM 66.3M
  • NHTC 56.0M
  • IPO Year
  • ADVM 2014
  • NHTC 1995
  • Fundamental
  • Price
  • ADVM $3.54
  • NHTC $4.62
  • Analyst Decision
  • ADVM Strong Buy
  • NHTC
  • Analyst Count
  • ADVM 4
  • NHTC 0
  • Target Price
  • ADVM $19.75
  • NHTC N/A
  • AVG Volume (30 Days)
  • ADVM 84.4K
  • NHTC 45.2K
  • Earning Date
  • ADVM 11-03-2025
  • NHTC 10-29-2025
  • Dividend Yield
  • ADVM N/A
  • NHTC 17.22%
  • EPS Growth
  • ADVM N/A
  • NHTC N/A
  • EPS
  • ADVM N/A
  • NHTC 0.03
  • Revenue
  • ADVM $1,000,000.00
  • NHTC $42,087,000.00
  • Revenue This Year
  • ADVM $1,836.70
  • NHTC N/A
  • Revenue Next Year
  • ADVM N/A
  • NHTC N/A
  • P/E Ratio
  • ADVM N/A
  • NHTC $152.30
  • Revenue Growth
  • ADVM N/A
  • NHTC N/A
  • 52 Week Low
  • ADVM $1.78
  • NHTC $4.02
  • 52 Week High
  • ADVM $8.56
  • NHTC $6.89
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 71.73
  • NHTC 59.11
  • Support Level
  • ADVM $2.93
  • NHTC $4.20
  • Resistance Level
  • ADVM $3.25
  • NHTC $4.45
  • Average True Range (ATR)
  • ADVM 0.22
  • NHTC 0.12
  • MACD
  • ADVM 0.05
  • NHTC 0.03
  • Stochastic Oscillator
  • ADVM 95.40
  • NHTC 76.38

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About NHTC Natural Health Trends Corp.

Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.

Share on Social Networks: